These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Humoral regulation of plasma opsonic fibronectin levels: its role in reticuloendothelial recovery after RE blockade.
    Author: Roccario E, Saba TM, Cho E.
    Journal: Adv Shock Res; 1981; 5():57-66. PubMed ID: 7304331.
    Abstract:
    The present study in rats evaluated the concept that a humoral factor regulates opsonic fibronectin levels. Intravenous administration of gelatin-coated particles depletes immunoreactive opsonic fibronectin by 95% within 30 minutes. Partial restoration of opsonic protein was observed by 3 hours with complete recovery 6-24 hours. Post-blockade serum was then evaluated with respect to this humoral factor. Controls were given either normal serum or serum rendered fibronectin-deficient by affinity chromatography. Affinity-adsorbed fibronectin-deficient serum did not increase immunoreactive opsonic fibronectin. Injection of normal serum resulted in the expected elevation in fibronectin due to its fibronectin content. In contrast, injection of fibronectin-deficient serum obtained during RE blockade dramatically elevated (P less than 0.02) immunoreactive opsonic fibronectin to 160.6 +/- 14% of control levels by 3 hours. Thereafter, fibronectin levels returned to control over the 6-24 hour period. Our temporal studies suggest that a circulating transferable factor, which may be a hormone, may influence the synthesis and/or release of opsonic fibronectin.
    [Abstract] [Full Text] [Related] [New Search]